SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-20-000166
Filing Date
2020-10-02
Accepted
2020-10-02 08:35:45
Documents
19
Period of Report
2020-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-20200930.htm   iXBRL 8-K 60462
2 EX-2.1 a202010018-kex21.htm EX-2.1 477118
3 EX-10.1 a202010018-kex101.htm EX-10.1 154667
4 EX-10.2 a202010018-kex102.htm EX-10.2 286255
5 PRESS RELEASE a202010018-kex991.htm EX-99.1 10885
11 LOGO pdllogoa3511.jpg GRAPHIC 123123
  Complete submission text file 0000882104-20-000166.txt   1420459

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pdli-20200930.xsd EX-101.SCH 2405
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pdli-20200930_cal.xml EX-101.CAL 698
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pdli-20200930_def.xml EX-101.DEF 1631
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pdli-20200930_lab.xml EX-101.LAB 23970
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pdli-20200930_pre.xml EX-101.PRE 12634
12 EXTRACTED XBRL INSTANCE DOCUMENT pdli-20200930_htm.xml XML 10480
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 201218134
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences